Abstract
Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Current Respiratory Medicine Reviews
Title: Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia
Volume: 6 Issue: 1
Author(s): Paula Ramirez, Miquel Ferrer and Antoni Torres
Affiliation:
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Abstract: Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Export Options
About this article
Cite this article as:
Ramirez Paula, Ferrer Miquel and Torres Antoni, Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820395
DOI https://dx.doi.org/10.2174/157339810790820395 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toll-Like Receptors in Skin Infections and Inflammatory Diseases
Infectious Disorders - Drug Targets Perceval Sutureless Valve – are Sutureless Valves Here?
Current Cardiology Reviews Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Chemistry and Pharmacology of Neglected Helminthic Diseases
Current Medicinal Chemistry The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease
Reviews on Recent Clinical Trials The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design Methadone and the Heart: What the Clinician Needs to Know
Current Drug Abuse Reviews Brucella Carbonic Anhydrases: New Targets for Designing Anti-Infective Agents
Current Pharmaceutical Design FDG-PET/CT for Systemic Infections
Current Molecular Imaging (Discontinued) Current and Future Approaches to the Prevention and Treatment of Staphylococcal Medical Device-Related Infections
Current Pharmaceutical Design Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews Current Evidence on the Evaluation and Management of Fever Without a Source in Infants Aged 0-90 Days: A Review
Reviews on Recent Clinical Trials The Radionuclide Molecular Imaging and Therapy of Neuroendocrine Tumors
Current Cancer Drug Targets Polyproline and Triple Helix Motifs in Host-Pathogen Recognition
Current Protein & Peptide Science Novel Antimicrobial Agents Against Multi-drug-resistant Gram-positive Bacteria: An Overview
Recent Patents on Anti-Infective Drug Discovery Pharmacology of Cyclic Peptides: Vancomycin and Oxytocin as Paradigms
Protein & Peptide Letters Genome Variability in Gram-Positive Pathogenic Bacteria - Impact on Virulence and Evolution
Current Genomics Inpatient Care of the HIV Infected Patient in the Highly Active Antiretroviral Therapy (HAART) Era
Current HIV Research In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets
Infectious Disorders - Drug Targets